Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026
Go back to Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.04 -0.17 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.21 | 52 Week High | $18.00 | |||
| Open | $5.32 | 52 Week Low | $6.91 | |||
| Day High | $5.33 | P/E | N/A | |||
| Day Low | $5.00 | EPS | $-0.67 | |||
| Volume | 904,771 | |||||
